MEDIROM Healthcare Technologies Inc ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $52.7M+8.8% YoYTTM through 31 Dec 2024
Net Income $945.3K+15.4% YoYTTM through 31 Dec 2024
Free Cash Flow -$1.9BTTM through 31 Dec 2024
Margins
| Current | |
|---|---|
| Gross Margin | 27.1% |
| EBITDA Margin | 3.3% |
| Operating Margin | -0.2% |
| Net Margin | 1.8% |
Returns
11.6%ROE
1.7%ROA
Balance Sheet Health
Debt / Equity3.33x
Net Debt$3.6B
Cash & Equivalents$329.4M
Quality Metrics
FCF Margin-3,593.0%
Dividend
No dividend
Segment Performance
No segment data available.
Financials converted at 156.9950.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.